Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-1-2
|
pubmed:abstractText |
Microvessel density (MVD) and expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), acting as a highly specific inducer of angiogenesis, were evaluated in tissue specimens of 25 patients with squamous cell cancer of the vulva. MVD was quantified by immunostaining for factor VIII-related antigen at one field of 0.25 mm2. VPF/VEGF expression was evaluated immunohistochemically using a monoclonal anti-VEGF antibody. FIGO stages I, II, and III were diagnosed in 12, 7, and 6 patients, respectively. MVD >20/field was found in 10 of 25 tumors and moderate or strong expression of VPF/VEGF in 10 of 25 tumors. High MVD was significantly more frequent in tumors with moderate or strong VPF/VEGF expression compared to tumors with no or weak VPF/VEGF expression (P = 0.01). Overall survival rates of patients with tumors of high MVD (P = 0.01) and strong VPF/VEGF expression (P < 0.01) were significantly poorer compared to those patients with low MVD or poor VPF/VEGF expression. Strong VPF/VEGF expression and high MVD are considered important parameters of tumor angiogenesis and therefore are related to poor survival probability in vulvar cancer patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0090-8258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
204-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8910628-Adult,
pubmed-meshheading:8910628-Aged,
pubmed-meshheading:8910628-Aged, 80 and over,
pubmed-meshheading:8910628-Carcinoma, Squamous Cell,
pubmed-meshheading:8910628-Endothelial Growth Factors,
pubmed-meshheading:8910628-Female,
pubmed-meshheading:8910628-Humans,
pubmed-meshheading:8910628-Lymphokines,
pubmed-meshheading:8910628-Microcirculation,
pubmed-meshheading:8910628-Middle Aged,
pubmed-meshheading:8910628-Neovascularization, Pathologic,
pubmed-meshheading:8910628-Prognosis,
pubmed-meshheading:8910628-Survival Analysis,
pubmed-meshheading:8910628-Vascular Endothelial Growth Factor A,
pubmed-meshheading:8910628-Vascular Endothelial Growth Factors,
pubmed-meshheading:8910628-Vulvar Neoplasms
|
pubmed:year |
1996
|
pubmed:articleTitle |
Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer.
|
pubmed:affiliation |
Department of Gynecology and Obstetrics, University Hospital of Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|